VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $765,000 | +16.4% | 31,150 | -4.5% | 0.30% | +24.2% |
| Q2 2016 | $657,000 | -19.1% | 32,615 | +5.6% | 0.24% | -16.7% |
| Q1 2016 | $812,000 | -69.4% | 30,890 | +18.2% | 0.29% | -65.3% |
| Q4 2015 | $2,656,000 | -6.2% | 26,130 | +64.7% | 0.83% | -12.3% |
| Q3 2015 | $2,831,000 | -23.1% | 15,870 | -4.2% | 0.95% | -19.9% |
| Q2 2015 | $3,681,000 | +0.5% | 16,570 | -10.1% | 1.18% | +7.5% |
| Q1 2015 | $3,661,000 | +22.1% | 18,430 | -12.0% | 1.10% | +24.2% |
| Q4 2014 | $2,999,000 | +16.7% | 20,955 | +7.0% | 0.88% | +16.4% |
| Q3 2014 | $2,569,000 | +6.2% | 19,580 | +2.1% | 0.76% | -4.8% |
| Q2 2014 | $2,419,000 | -2.1% | 19,180 | +2.4% | 0.80% | -8.5% |
| Q1 2014 | $2,470,000 | +22.8% | 18,735 | +9.4% | 0.87% | +25.1% |
| Q4 2013 | $2,011,000 | – | 17,125 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |